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Abstract
Tumours, abscesses, cysts, scars and fractures are familiar types of what we shall
call pathological continuant entities. The instances of such types exist always in
or on anatomical structures, which thereby become transformed into pathological
anatomical structures of corresponding types: a fractured tibia, a blistered thumb, a
carcinomatous colon. In previous work on biomedical ontologies we showed how the
provision of formal deﬁnitions for relations such as is a, part of and transformation
of can facilitate the integration of such ontologies in ways which have the potential
to support new kinds of automated reasoning. We here extend this approach to the
treatment of pathologies, focusing especially on those pathological continuant entities
which arise when organs become affected by carcinomas. Copyright  2006 John
Wiley & Sons, Ltd.
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Background
The Ontology of Biomedical Reality (OBR; Rosse
et al., 2005) provides a preliminary classiﬁcation
of organismal continuant entities, shown partially
in Table 1.
Continuant entities are entities which endure
self-identically through time while undergoing a
variety of different sorts of changes of size, shape,
location, internal structure and so forth (Grenon
et al., 2004). The OBR classiﬁcation distinguishes
two high-level universals in the realm of organ-
ismal continuants: material anatomical entity and
material pathological entity, which are disjoint in
the sense that they share no instances in reality.
In accordance with the classiﬁcation schemes
presupposed in standard treatises of pathology,
OBR conceives the universal material pathological
entity as comprehending subtypes such as tumour,
ulcer, portion of pus, which have no equivalents in
normal, healthy organisms.
In addition, however, we need to do justice to
those anatomical structures which serve as the hosts
or bearers of abnormalities of the types mentioned
and which have, as a consequence, become pre-
disposed to malfunction and disease. This means
that in addition to universals such as colon carci-
noma and empyema of the lung, which are instan-
tiated by corresponding pathological lesions, we
need also to include universals such as carcino-
matous colon and empyematous lung, which are
instantiated by those anatomical structures whose
physiological functions have been altered by those
lesions.
We thus modify the classiﬁcation in Rosse et al.
(2005) by recognizing two kinds of pathological
continuant entity, which we shall call pathologi-
cal formation and pathological anatomical struc-
ture, respectively. Instances of the latter serve
as the bearers or hosts for instances of the for-
mer.
As in the original classiﬁcation, so also here,
we take the non-pathological universals from the
Foundational Model of Anatomy (FMA; Rosse and
Mejino, 2003; http://sig.biostr.washington.edu/
projects/fm/) as our starting point. The FMA
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Table 1. A part of the OBR classiﬁcation of continuant
entities
1. Material anatomical entity
(a) Anatomical structure
(i) Canonical anatomical structure
(ii) Variant anatomical structure
(b) Portion of canonical body substance (portion of urine,
portion of blood)
2. Material pathological entity
(a) Pathological structure (neoplasm, inﬂammatory structure,
degenerated structure)
(b) Portion of pathological body substance (portion of pus,
portion of amyloid)
is a structured representation of the anatomy of
instances (particulars, individuals), whose con-
stituent nodes are representations of those ‘multi-
ply located anatomical entities (i.e. universals) that
exist in the instances (particulars) that they sub-
sume’ (Rosse and Mejino, 2003).
The universal anatomical structure is deﬁned by
the FMA as follows:
‘An anatomical structure is a material physical
anatomical entity which has inherent 3D shape and
is generated by coordinated expression of the organ-
ism’s own structural genes.’
The particular entities which satisfy this deﬁ-
nition, and which are thus instances of the cor-
responding universal, include cells and organs as
well as cardinal body parts, such as the head and
trunk.
For reasons outlined in Rosse and Mejino (2003),
the FMA is restricted to anatomical entities which
are ‘typical’ in the sense that they can be con-
ceived as belonging to an ‘idealized’, healthy male
or female adult human being (such entities are also
identiﬁed in the literature of the FMA as ‘canoni-
cal’ entities). But there are also ‘typical’ entities in
the realm of pathologies. The cases of small cell
carcinoma of the lung and adenocarcinoma of the
colon discussed in pathology textbooks are ‘typi-
cal’ in the sense that they possess the characteristics
by which entities of the given types may be most
readily distinguished from other pathological for-
mations. It is the task of pathology as an empirical
science to specify the characteristics by which sub-
types and modiﬁcations of these ‘typical’ instances
can be speciﬁed.
An anatomical structure is pathological when-
ever:
1. It has come into being as a result of changes
in some pre-existing canonical anatomical struc-
ture through processes other than the expression
of the normal complement of genes of an organ-
ism of the given type.
2. It is predisposed to have health-related conse-
quences for the organism in question manifested
by symptoms and signs.
An organism (or part of an organism) is diseased
if and only if:
1. It includes among its parts pathological forma-
tions which:
2. Compromise the organism’s physiological pro-
cesses to the degree that they give rise to symp-
toms and signs.
Symptoms and signs, too, would require a
detailed ontological treatment which, however, we
do not attempt here.
An organism (or part of an organism) is healthy
if and only if it is not diseased.
So long as a pathological continuant does not
interfere with physiological processes, we have
pathology but no disease. A pathological continuant
entity can thus exist even in a healthy organism. A
single transformed epithelial cell need give rise to
no health-related consequences, but it is a cancer
in situ at the cell level nonetheless.
In what follows, now, we stipulate that ‘canon-
ical’ and ‘variant’ shall comprehend exclusively
non-pathological instances of the correspond-
ing anatomical universals. Pathological anatomi-
cal structures are thus distinguished from variant
anatomical structures (such as middle lobe of left
lung) by the fact that the latter are not predisposed
to manifest health-related consequences.
Varieties of pathological continuant
In the light of considerations discussed in the
Background section, we enhance OBR by sorting
pathological continuant entities into two ontolog-
ically disjoint categories, pathological formation
and pathological anatomical structure. Following
the scheme of OBR, we then distinguish in each
category independent and dependent continuant
entities. Independent continuant entities can be
deﬁned for present purposes as continuant entities
which have mass (and are thus material); dependent
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continuant entities as continuant entities which do
not have mass (and are thus immaterial) (Rosse
et al., 2005).
Tumours and abscesses are examples of inde-
pendent pathological continuants, and so also are
carcinomatous colons, wounded knees, punctured
eardrums and fractured tibias. Examples of depen-
dent pathological continuants are wounds, punc-
tures, fractures and abscess cavities. The latter
belong ontologically in the same family as bound-
aries and holes (Casati and Varzi, 1994). Indeed, the
relation between dependent and independent patho-
logical continuants is formally analogous to the
relation of boundary-dependence deﬁned in Smith
(1997).
Independent pathological continuants can now be
subdivided into:
• Pathological formations, e.g. a carcinoma, a blis-
ter, an ulcer, which are newly formed continuant
entities evolving in some larger anatomical struc-
ture.
• Pathological anatomical structures, e.g. a carci-
nomatous lung, a blistered thumb, an ulcerated
colon.
• Portions of pathological body substance, e.g. a
portion of pus, a portion of amyloid.
It is upon the ﬁrst two of these categories that
we shall concentrate here. Our task is to understand
the relations between such continuant universals
as carcinomatous lung, lung and carcinoma. We
must ﬁrst, however, touch brieﬂy on pathological
occurrent entities.
Varieties of pathological occurrent
Like all organismal continuants, pathological con-
tinuant entities are tied in every case to occurrent
entities (happenings, changes, events, processes),
which unfold themselves through time in succes-
sive temporal phases (Rosse et al., 2005; Grenon
et al., 2004).
As noted in Rosse and Mejino (2003), there are
certain basic types of processes involving biolog-
ical continuants which, in various combinations,
bring about phenotypic changes on all levels of
granularity. These are processes of neogenesis,
deletion and spatial or structural rearrangement
of constituents, the latter often manifested as pro-
cesses of invasion.
Often these processes entail speciﬁc sorts of
changes in a single anatomical structure which
preserves its identity over time. An instance of
a given type of canonical anatomical structure
at one stage may be identical to an instance of
a pathological anatomical structure at some later
stage.
Following Smith et al. (2005; http://obo.
sourceforge.net/relationship/), we call such pro-
cesses transformations; they are types of pheno-
typic change which are observed not only in the
aetiology of pathological continuants but also in
embryonic development and in growth and age-
ing. A colon remains a colon, indeed it remains
one and the same colon, even when some of its
parts have been transformed into a tumour of a
size capable of obstructing its lumen and disrupt-
ing the ordered arrangement of layers in the colon
wall. An epithelial cell of the colon in which a
carcinogenic transformation has taken place is one
and the same entity as the canonical (healthy) colon
epithelial cell which existed earlier.
In reﬂection of the existence of such transfor-
mations, the OBR classiﬁcation has been revised
in such a way as to include pathological anatomi-
cal structure as a subtype of anatomical structure
(Figure 1).
Such transformations occur even in the case of
congenital pathological continuants, where we can
in every case identify embryonic or fetal canonical
anatomical equivalents whose development into
more mature forms has been arrested or interfered
with as a consequence of the failure or disruption
of developmental processes. Thus, in the case
of congenital neoplasms, the lung is formed in
an embryo of 4 or 5 weeks of gestational age
and it has existed before any of its cells became
neoplastically transformed. Similarly, various types
of congenital cardiac abnormality correspond to
embryonic or fetal canonical anatomical structures
arrested at speciﬁc stages of cardiac development.
A second subfamily of phenotypic changes con-
sists of processes of derivation (Smith et al., 2005),
where matter is reorganized in such a way as to give
rise to new entities which take the place of enti-
ties existing earlier, as for example in cases of cell
division or fusion. A process of neoplastic change
may not alter the essential characteristics of the few
epithelial cells it primarily affects (the cells retain
their identity), but the tumour that results from the
uncontrolled proliferation of these modiﬁed cells
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Figure 1. Revised OBR classiﬁcation
becomes a new entity in virtue of its phenotype.
The tumour is derived from normal cells of the
colon, but it is not a transformation of any pre-
existing single entity.
Here again, such processes of derivation occur
even in the case of congenital pathological con-
tinuants. Spina biﬁda arises through disruption of
neural and vertebral fusion processes. The patho-
logical continuants that we observe postnatally are
then derived from abnormal embryonic or fetal
structures, each of which in turn derives from a
normal embryonic or fetal structure of an earlier
developmental stage.
Elements of a formal theory
Existing classiﬁcations of pathologies are con-
tained, for example, in the International Classiﬁ-
cation of Diseases (ICD10; http://www.cdc.gov/
nchs/about/major/dvs/icd10des.htm), SNOMED
CT (http://www.snomed.org/), the NCI Thesaurus
(http://nciterms.nci.nih.gov/NCIBrowser), the
Pathology Descriptive Terminology (http://cal.vet.
upenn.edu/pathterm/menu.htm) and OBO’s Dis-
ease Ontology (http://sourceforge.net/projects/
diseaseontology/). Unfortunately, none of these
systems has the resources to support reason-
ing about pathologies in systematic ways. This
is because none of them incorporates a for-
mal ontological framework with the facility to
represent the different types of pathological and
non-pathological continuant entities and the rela-
tions between them.
In the classiﬁcation summarized in Figure 1,
the universal anatomical structure comprehends as
subuniversals not merely canonical and variant
anatomical structure but also pathological anatom-
ical structure. Note that this is consistent with the
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deﬁnition of ‘anatomical structure’ provided above.
(We here leave out of account discussions of patho-
logical surfaces, pathological states and other non-
material pathological continuant entities treated in
Rosse et al. (2005), and also of biological patholo-
gens such as bacteria and parasites, which are not
parts of the organism in question. We also omit
from the classiﬁcation non-organismal substances,
such as carcinogens, poisons and irritants of various
sorts.)
Our classiﬁcation can now be expanded through
axioms asserting is a and part of relations
between corresponding universals such as:
canonical colonic epithelial cell is a colonic epithe-
lial cell
pathological colonic epithelial cell is a colonic epi-
thelial cell
pathological colonic epithelial cell is a pathological
anatomical structure
tuberculouslobeofleftlungis apathologicalanatom-
ical structure
canonical colonic epithelial cell is a canonical struc-
ture
pathological colonic epithelial cell part of colonic
epithelium
By making use of information in the FMA we can
then infer for example that:
pathological colonic epithelial cell part of colonic
mucosa
pathological colonic epithelial cell part of colon wall
pathological colonic epithelial cell part of colon
and so on.
We use variables A,B,C ... to range over uni-
versals (types) of continuants. We use a,b,c,c ,
... to range over the instances of such universals
(particulars in reality, such as you and me, your
tibia or your pleural cavity), and t,t ,...to range
over instants of time.
Following Smith et al. (2005), is a and part of,
as relations between continuant universals, can be
deﬁned as follows:
Ai saB= def. for all c, t,i fc instance of A at t
then c instance of B at t.
A part of B = def. for all a, t,i fa instance of A at
t then there is some b such that: b instance of B at
t and a part of b at t.
Part of, here, is the instance-level part relation
(which holds, for example, between this particu-
lar cell and this particular lung at this particular
instant of time). This use of instance-level relations
to deﬁne relations between universals, and also
the all-some structure employed in the deﬁnition
of part of, are characteristic of almost all relations
between universals of the sort treated by biomed-
ical ontologies, although this fact is not always
recognized consistently in such ontologies.
Note that it follows from our deﬁnition of part of
that pathological colonic epithelial cell stands in
the part of relation not only to pathological colon
but also to colon.
Quantiﬁcation over time in the above is designed
to capture formally the temporal relations between
instances of biological universals. Such relations
have not been addressed in ontologies thus far, and
even ontologies distinguishing successive stages of
development of organisms or pathologies have not
incorporated machinery for dealing directly with
times (Aitken, in press). The reference to times
allows us to do justice to the fact that one and the
same entity can instantiate different universals and
gain and lose parts in the course of time. Note that
this reference is perfectly generic, which means that
the deﬁnitions provided can be applied by users,
even in the absence of speciﬁc time-indexed data.
The genesis of pathological entities
Each pathological formation which is a carcinoma
of the left lung stands in the instance-level part of
relation to that pathological left lung which serves
as its host. On the level of universals, we have
correspondingly:
carcinoma of left lung part of left lung,
although not, of course, the reciprocal relation (left
lung has part carcinoma of left lung).
The associated transformation of relation is
deﬁned as follows (Smith et al., 2005):
A transformation of B = def. for all t and all c,i fc
instance of A at t, then there is an earlier time t  at
which c instance of B,
and is illustrated for example by:
red blood cell transformation of reticulocyte
fetus transformation of embryo
colon epithelial cell transformation of colon epithe-
lial cell precursor.
Relations of this sort are not recorded even in an
otherwise relation-rich terminology resource such
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as the National Cancer Institute Thesaurus (NCIT),
where, for example, no relations are asserted
between the two classes abnormal cell and normal
cell, not even that they have a common parent, cell
(Ceusters et al., in press). Transformation relations
are also absent in the SNOMED CT terminology
(http://nciterms.nci.nih.gov/).
A type of relation which we do ﬁnd in SNOMED
CT is that of location, which is there expressed for
example in:
lung cyst ﬁnding site lung structure
Better, however, would be to eliminate the epis-
temological connotations of ‘ﬁnding site’b yu s i n g
a relation such as OBO’s located in (Smith et al.,
2005):
A located in B = def. for all a, t,i fa instance of A
at t there is some b such that: b instance of B at t
and a located in b at t.
Here located in is the location relation between
instances obtaining for example between your brain
and your cranial cavity at a given point of time.
Signiﬁcantly, located in, the corresponding relation
between universals, has the same all–some form
which we encountered in the deﬁnitions of part of
and transformation of above.
This framework can now be used as a platform
for reasoning with axioms governing ontological
relations in the domains of pathologies provided by
other systems. PathBase (http://eulep.anat.cam.
ac.uk/Pathology Ontology/MPATHdynamic.
php), for example, provides a subsumption hier-
archy for pathological processes, to which are
adjoined axioms pertaining to the corresponding
pathological continuants, for example to the effect
that:
endoplastic reticulum defect is a subcellular defect
This axiom can be used with the colon cell
assertions above to generate implications such as:
pathological colon epithelial cell with endoplastic
reticulum defect is a pathologicalcolonepithelialcell
with subcellular defect
endoplastic reticulum defect located in endoplastic
reticulum
and so on.
Structures, patterns, processes and
stages
The neoplastic processes involved in colon carci-
noma are borne by an anatomical structure, the
colon itself, as it is transformed over time. In their
earlier stages these processes unfold themselves
primarily in certain epithelial cells; in their later
stages they will spread to the submucosa and mus-
cle coats. Even as the latter become involved in and
engulfed by the spreading cancer, however, they
will remain unaffected so far as the nature of their
cells is concerned, although the canonical arrange-
ment of the components invaded by the cancer may
be disrupted.
An inﬂammation and hypertrophy of the synovial
membrane of the knee joint, similarly, is a patho-
logical process which is initially conﬁned to the
synovial membrane itself, but then gives rise to
degeneration of intra- and periarticular structures,
as happens, for example, in the case of rheumatoid
arthritis. Such multi-stage processes are captured in
current bio-ontologies, for example, via the distinc-
tion between acute, subacute and chronic stages. In
a complete representation one would need to spec-
ify the kinds of patterns associated with each such
stage, and also the kinds of processes which yield
them.
The processes with which we are dealing here
are not processes of transformation but rather of
invasion or inﬁltration, processes of a type which
yield patterns of continuant entities related together
in speciﬁc ways. Such patterns can be represented
by means of compound terms, such as:
muscle layer of colon invaded-by colon carcinoma
colon carcinoma of liver metastasis-of carcinoma of
sigmoid colon
and so on (Johansson, 1998). Here hyphens (-)
are used in place of underscore separators ( )t o
mark the fact that we are dealing with names (of
complex universals) rather than with assertions (of
relations).
The instances of complex universals of the men-
tioned sorts are themselves complex continuant
entities. We ﬁnd in all anatomy-based classiﬁca-
tions of carcinomas the generation of such complex
names by means of syntactic operators of a type
which have been recently investigated in relation
to their use in the Gene Ontology (Ogren et al.,
2004; Kumar et al., 2004; Mungall, 2004).
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Some binary operators of this type have been
used already in the above, for example, the operator
‘with’ in ‘pathological colon epithelial cell with
subcellular defect’.
As is shown in (Kumar and Smith, 2005),
however, such operators have to be used with
caution. The SNOMED term ‘empyema of the
gallbladder without mention of calculus’ refers not
to a special sort of empyema, but rather to a case
of empyema that has been entered in a record in a
certain way. Terms such as these can give rise to
errors in reasoning (Kumar et al., 2004). Moreover,
because classiﬁcations developed with their aid
must fall short of the ideal of single inheritance
(in which every node has at most one is a parent),
these classiﬁcations themselves are subject to the
characteristic kinds of errors which ﬂow from is a
overloading (Kumar and Smith, 2005).
Cancer staging
The framework sketched above can be exploited to
capture, in a formal way, some of the information
contained in systems for cancer staging, such as the
TNM (tumour, node, metastasis) system, systems
which do not, as currently constituted, sustain for-
mal reasoning (American Joint Committee on Can-
cer, 2002). Here, ‘T’ refers to information about
size and location pertaining to a primary tumour;
‘N’ records whether the cancer has metastasized
to regional lymph nodes that drain ﬂuid from the
area of the tumour, and ‘M’ stands for metastasis,
and indicates whether the cancer has metastasized
to distant sites in the body, for example, from the
colon to the liver.
A stage is conceived by the TNM system as
a portion of the life or history of an entity, dur-
ing which speciﬁc characteristics remain relatively
constant. More correctly, however, it should be
conceived as the pattern which endures — at a
certain level of granularity — throughout the cor-
responding period, a pattern which can be cap-
tured formally by means of compound terms (‘mus-
cle layer of colon invaded-by colon carcinoma’)
capturing parthood, location and other relations
between continuant entities along the lines indi-
cated above.
The successive T stages of colorectal carcinoma
are deﬁned in the AJCC Cancer Staging Manual
(American Joint Committee on Cancer, 2002) as
follows:
Tis: Carcinoma in situ.
T1: Tumour invades submucosa.
T2: Tumour invades muscularis propria.
T3: Tumour invades through the muscularis propria
into the subserosa, or into non-peritonealized
pericolic or perirectal tissues.
T4: Tumour directly invades other organs or
structures, and/or perforates visceral peritoneum.
Tis designates that stage during which cancer cells
are conﬁned to the luminal side of the epithelial
basement membrane (intraepithelial) or the lamina
propria (intramucosal), with no extension through
the muscularis mucosae into the submucosa, the
latter pattern being captured by the compound
expression:
colon submucosa invaded-by colon carcinoma
T2 designates a stage in the unfolding of the
carcinoma process during which the carcinoma has
invaded the muscular layers of the colon wall.
N1 is a stage in which cancer has metastasized
to one to four lymph nodes. M1 a stage where
a metastasis is present in a part of the body not
directly connected to the colon.
We can now assert, for example, that a patholog-
ical entity of the type:
stage T2N1M1 colon carcinoma
must be a transformation of either a T1N1M1 or a
T2N0M1 carcinoma. We can infer further that, if
a carcinoma is a transformation from T1N1M1 to
T2N1M1, then a pattern of the type:
muscularis mucosae invaded-by colon carcinoma
has become instantiated.
If there is a transformation from T2N0M1 to
T2N1M1, then the last process to take place before
this transformation was of the type lymph node
involvement. If there is a transformation from
T2N1M0 to T2N1M1, then the last process to take
place was of the type metastasis to distant site.A n d
so on.
Classifying carcinomas through the FMA
To create a robust classiﬁcation of carcinomas,
we need to ﬁnd ways of linking the nodes of an
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ontology of pathological continuant entities with
appropriate nodes in the FMA and in reference
ontologies of attributes, of diseases, of molec-
ular biology, and so forth. The corresponding
relations will be either synchronic (is a, part of,
located at, etc.) or diachronic (derived from, trans-
formation of ).
The FMA, as already noted, does not take
account of pathological continuant entities within
its hierarchy of anatomical universals. On the basis
of axioms of the sorts presented above, however,
we can use the FMA as a valuable resource to
support reasoning about carcinomas.
The goal is to realize a scenario in which
each given type of (for example) Tis small cell
carcinoma would be represented as a node in
a reference ontology of pathological continuant
entities, and linked via the located at relation to
the FMA and to a cancer staging knowledge base
in a way which would allow us to infer, for
example, that the carcinoma in question is located
in the mucosa of a respiratory bronchiole in the
lateral basal segment of the left lung. Compound
expressions, such as ‘carcinomatous mucosa of a
respiratory bronchiole in the lateral basal segment
of the left lung’, should not then be used to refer
to universals in a pre-existing reference ontology.
Rather, they should be generated on the ﬂy to meet
the speciﬁc needs of the reasoner in speciﬁc types
of contexts.
If we generate a strictly location-based classi-
ﬁcation of carcinomas, via pointers going from
the FMA to a pathology reference ontology, then
the classiﬁcation thereby generated would have the
advantage that it would be more complete than
a post-coordinated ontology of the type that is
currently available in terminologies and ontologies
such as SNOMED CT or the NCI Thesaurus, as
it will necessarily take care, in automatic fash-
ion, even of rare carcinomas. Thus, the universal
carcinoma of wall of alveolar duct has instances
in physical reality, but they are encountered too
infrequently to be included in the usual disease
ontologies.
Unfortunately, however, it would be too daunting
a task to generate a new ontology reﬂecting all
the different ways in which anatomical continuants
may become tainted by the presence of pathological
continuants of different sorts. For such an ontology
would need to duplicate essentially the entire
FMA for every kind of pathology universal, thus
not only for cancerous colon and carcinomatous
colon, but also for sarcomatous colon, inﬂamed
colon, acutely inﬂamed colon, chronically inﬂamed
colon, atrophied colon, hypertrophied colon, colon
containing parasite, colon containing parasite of
type A, colon containing parasite of type B, and
so on.
We should not, therefore, strive to create a ref-
erence ontology along all the axes that prevail in
current terminologies, but rather build a reference
ontology of types of pathologies which can be used,
together with the FMA and other domain reference
ontologies, to generate local classiﬁcations accord-
ing to speciﬁc needs. This would bring also the
advantage that we can preserve the beneﬁts of sin-
gle inheritance in reference ontologies, even if we
need to accept multiple inheritance in classiﬁca-
tions created for speciﬁc purposes.
Reasoning with the FMA
Given a classiﬁcation of types of carcinomas based
on the anatomical ontology of the FMA along the
lines described, we could use the is a and part of
relations present in the FMA to derive relations
between the corresponding carcinoma structures on
the basis of rules, such as:
from: Ai saB(in FMA)
infer: carcinoma of A is a carcinoma of B
yielding, for example:
carcinoma of lung is a carcinoma of organ
Of course, we also have:
carcinoma of lung is a carcinoma of anatomical entity
and while the latter assertion captures no knowl-
edge which is of immediate clinical signiﬁcance, it
may be of importance in ensuring completeness of
the set of inferences we can make in a reasoning
system.
We also have the rule:
from: A part of B (in FMA)
infer: carcinoma of A is a carcinoma of B.
Thus, from:
ascending colon part of colon
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we can infer:
ascending colon carcinoma is a colon carcinoma
And from:
upper lobe of left lung part of left lung
we can infer:
carcinoma of upper lobe of left lung is a lung carci-
noma
A special issue arises where we employ anatomical
expressions containing modiﬁers like ‘whole’ or
‘complete’. The part of components of the organ
left lung include upper lobe of left lung and
lower lobe of left lung. These form an exhaustive
partition, so that the mereological sum of the
two organ components is the whole left lung.
While within the FMA ‘whole left lung’ and ‘left
lung’ are treated as synonyms, for purposes of the
classiﬁcation of disorders the two expressions need
to be distinguished (Hahn et al., 2004). This is
because we have, for example:
upper lobe of left lung part of whole left lung
lower lobe of left lung part of whole left lung
carcinoma of upper lobe of left lung is a carcinoma
of left lung
but not:
carcinoma of upper lobe of left lung is a carcinoma
of whole left lung.
Conclusion
We have sketched a formal approach to the ontol-
ogy of pathological continuant entities, resting
on the distinction between two types of patho-
logical continuant entity, called pathological for-
mations and pathological anatomical structures,
respectively. The framework is intended to support
new types of reasoning about pathological entities
and about the ways in which they develop through
time, for example, in the domain of cancer staging.
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